245 related articles for article (PubMed ID: 37799386)
1. Arf6 as a therapeutic target: Structure, mechanism, and inhibitors.
Sun D; Guo Y; Tang P; Li H; Chen L
Acta Pharm Sin B; 2023 Oct; 13(10):4089-4104. PubMed ID: 37799386
[TBL] [Abstract][Full Text] [Related]
2. ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.
Dani N; Barbosa AJ; Del Rio A; Di Girolamo M
Curr Pharm Des; 2013; 19(4):624-33. PubMed ID: 23016858
[TBL] [Abstract][Full Text] [Related]
3. Activation machinery of the small GTPase Arf6.
Hongu T; Kanaho Y
Adv Biol Regul; 2014 Jan; 54():59-66. PubMed ID: 24139303
[TBL] [Abstract][Full Text] [Related]
4. Arf6 promotes cell proliferation via the PLD-mTORC1 and p38MAPK pathways.
Knizhnik AV; Kovaleva OV; Komelkov AV; Trukhanova LS; Rybko VA; Zborovskaya IB; Tchevkina EM
J Cell Biochem; 2012 Jan; 113(1):360-71. PubMed ID: 21928324
[TBL] [Abstract][Full Text] [Related]
5. Roles of Arf6 in cancer cell invasion, metastasis and proliferation.
Li R; Peng C; Zhang X; Wu Y; Pan S; Xiao Y
Life Sci; 2017 Aug; 182():80-84. PubMed ID: 28625359
[TBL] [Abstract][Full Text] [Related]
6. Exchange factor EFA6R requires C-terminal targeting to the plasma membrane to promote cytoskeletal rearrangement through the activation of ADP-ribosylation factor 6 (ARF6).
Kanamarlapudi V
J Biol Chem; 2014 Nov; 289(48):33378-90. PubMed ID: 25296758
[TBL] [Abstract][Full Text] [Related]
7. Calcium-regulated exocytosis of dense-core vesicles requires the activation of ADP-ribosylation factor (ARF)6 by ARF nucleotide binding site opener at the plasma membrane.
Vitale N; Chasserot-Golaz S; Bailly Y; Morinaga N; Frohman MA; Bader MF
J Cell Biol; 2002 Oct; 159(1):79-89. PubMed ID: 12379803
[TBL] [Abstract][Full Text] [Related]
8. Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis.
Hongu T; Yamauchi Y; Funakoshi Y; Katagiri N; Ohbayashi N; Kanaho Y
Small GTPases; 2016 Apr; 7(2):47-53. PubMed ID: 26909552
[TBL] [Abstract][Full Text] [Related]
9. Vesicular transport protein Arf6 modulates cytoskeleton dynamics for polar body extrusion in mouse oocyte meiosis.
Duan X; Zhang HL; Pan MH; Zhang Y; Sun SC
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):455-462. PubMed ID: 29208529
[TBL] [Abstract][Full Text] [Related]
10. ARF6-Rac1 signaling-mediated neurite outgrowth is potentiated by the neuronal adaptor FE65 through orchestrating ARF6 and ELMO1.
Chan WWR; Li W; Chang RCC; Lau KF
FASEB J; 2020 Dec; 34(12):16397-16413. PubMed ID: 33047393
[TBL] [Abstract][Full Text] [Related]
11. Arf6 in lymphatic endothelial cells regulates lymphangiogenesis by controlling directional cell migration.
Lin YC; Ohbayashi N; Hongu T; Katagiri N; Funakoshi Y; Lee H; Kanaho Y
Sci Rep; 2017 Sep; 7(1):11431. PubMed ID: 28900118
[TBL] [Abstract][Full Text] [Related]
12. AMPK promotes Arf6 activation in a kinase-independent manner upon glucose starvation.
Chen KJ; Hsu JW; Lee FS
J Cell Sci; 2022 Sep; 135(18):. PubMed ID: 36017701
[TBL] [Abstract][Full Text] [Related]
13. BRAG2a Mediates mGluR-Dependent AMPA Receptor Internalization at Excitatory Postsynapses through the Interaction with PSD-95 and Endophilin 3.
Fukaya M; Sugawara T; Hara Y; Itakura M; Watanabe M; Sakagami H
J Neurosci; 2020 May; 40(22):4277-4296. PubMed ID: 32341099
[TBL] [Abstract][Full Text] [Related]
14. CD13 tethers the IQGAP1-ARF6-EFA6 complex to the plasma membrane to promote ARF6 activation, β1 integrin recycling, and cell migration.
Ghosh M; Lo R; Ivic I; Aguilera B; Qendro V; Devarakonda C; Shapiro LH
Sci Signal; 2019 Apr; 12(579):. PubMed ID: 31040262
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway.
Hu B; Shi B; Jarzynka MJ; Yiin JJ; D'Souza-Schorey C; Cheng SY
Cancer Res; 2009 Feb; 69(3):794-801. PubMed ID: 19155310
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.
Ye Z; Hu Q; Zhuo Q; Zhu Y; Fan G; Liu M; Sun Q; Zhang Z; Liu W; Xu W; Ji S; Yu X; Xu X; Qin Y
Am J Cancer Res; 2020; 10(4):1182-1193. PubMed ID: 32368394
[TBL] [Abstract][Full Text] [Related]
17. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes.
Qi S; Su L; Li J; Zhang C; Ma Z; Liu G; Zhang Q; Jia G; Piao Y; Zhang S
J Exp Clin Cancer Res; 2019 Nov; 38(1):471. PubMed ID: 31752956
[TBL] [Abstract][Full Text] [Related]
18. Arf6 exchange factor EFA6 and endophilin directly interact at the plasma membrane to control clathrin-mediated endocytosis.
Boulakirba S; Macia E; Partisani M; Lacas-Gervais S; Brau F; Luton F; Franco M
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9473-8. PubMed ID: 24979773
[TBL] [Abstract][Full Text] [Related]
19. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
[TBL] [Abstract][Full Text] [Related]
20. Fbx8 makes Arf6 refractory to function via ubiquitination.
Yano H; Kobayashi I; Onodera Y; Luton F; Franco M; Mazaki Y; Hashimoto S; Iwai K; Ronai Z; Sabe H
Mol Biol Cell; 2008 Mar; 19(3):822-32. PubMed ID: 18094045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
